- Home
- HSCS vs SILO Comparison
HSCS vs SILO Comparison
Compare HSCS & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- SILO
- Stock Information
- Founded
- HSCS 2007
- SILO 2010
- Country
- HSCS United States
- SILO United States
- Employees
- HSCS N/A
- SILO N/A
- Industry
- HSCS Medical Specialities
- SILO Apparel
- Sector
- HSCS Health Care
- SILO Consumer Discretionary
- Exchange
- HSCS Nasdaq
- SILO Nasdaq
- Market Cap
- HSCS 9.9M
- SILO 8.0M
- IPO Year
- HSCS 2022
- SILO N/A
- Fundamental
- Price
- HSCS $3.16
- SILO $0.52
- Analyst Decision
- HSCS Strong Buy
- SILO
- Analyst Count
- HSCS 2
- SILO 0
- Target Price
- HSCS $10.50
- SILO N/A
- AVG Volume (30 Days)
- HSCS 25.5K
- SILO 813.6K
- Earning Date
- HSCS 12-15-2025
- SILO 11-12-2025
- Dividend Yield
- HSCS N/A
- SILO N/A
- EPS Growth
- HSCS N/A
- SILO N/A
- EPS
- HSCS N/A
- SILO N/A
- Revenue
- HSCS $6,250.00
- SILO $72,102.00
- Revenue This Year
- HSCS N/A
- SILO $1.86
- Revenue Next Year
- HSCS N/A
- SILO N/A
- P/E Ratio
- HSCS N/A
- SILO N/A
- Revenue Growth
- HSCS N/A
- SILO N/A
- 52 Week Low
- HSCS $2.52
- SILO $0.40
- 52 Week High
- HSCS $6.47
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- HSCS 36.80
- SILO 37.72
- Support Level
- HSCS $3.16
- SILO $0.53
- Resistance Level
- HSCS $3.43
- SILO $0.62
- Average True Range (ATR)
- HSCS 0.16
- SILO 0.06
- MACD
- HSCS -0.04
- SILO -0.01
- Stochastic Oscillator
- HSCS 1.67
- SILO 46.82
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.